Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KeyCorp (KEY) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance

NeoGenomics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

KeyCorp vs NeoGenomics Inc. Common Stock — how do they compare? KeyCorp trades at $19.83 (market cap $21.25B), while NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B). The key difference: KeyCorp is far larger — about 9.9× NeoGenomics Inc. Common Stock's market cap, and KeyCorp pays a 4.12% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold KeyCorp for 66 Days and NeoGenomics Inc. Common Stock for 0 Days on average.

KEYNEO
Market Cap
$21.25B$2.14B
Volume
17,676,9342,228,400
Sector
FinancialsHealth
52-Week High
$23.99$19.91
52-Week Low
$16.78$7.19
Typical Hold Time
66 Days0 Days
Enterprise Value
$34.43B$2.44B
Dividend Yield
4.12%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

KeyCorp

KeyCorp (KEY) trades at $19.79, down 1.49% on the day, with a bearish technical signal but strong fundamentals including a P/E of 11.64 and net income margin of 26.72%. Recent quarterly earnings have consistently beaten expectations, and the company maintains a $0.21 dividend. Analyst consensus is bullish with a $25.00 price target, though recent news highlights competitive dividend pressures.

The outlook for KEY is positive based on earnings momentum and valuation, but risks include interest rate sensitivity and frozen dividends. Upside potential exists if loan growth and fee income continue to drive revenue, yet investor sentiment is cautious amid technical weakness and macroeconomic uncertainty.

NeoGenomics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KEY

No sentiment data available yet.

NEO
100% Buy0% Sell
Avg holding period · 0 Days

About KeyCorp

With assets of over $170 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.

Read more on KEY →

About NeoGenomics Inc. Common Stock

NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.

Read more on NEO →